Literature DB >> 19571315

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.

Willem M Lijfering1, Nic J G M Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H Prins, Harry R Büller, Jan van der Meer.   

Abstract

Why men appear to have an increased risk of recurrent venous thrombosis compared with women is unknown. In a cohort study of families with thrombophilia, lifetime risk of recurrent venous thrombosis was assessed in men and women (n = 816). Adjusted relative risk of recurrence was 1.6 (95% CI, 1.3-2.0) in men compared with women. Women were younger at time of their first event (mean, 34 years vs 44 years; P < .001) and at time of recurrence (40 years vs 48 years, P < .001). After excluding provoked first and recurrent venous thrombosis, adjusted relative risk was 1.2 (95% CI, 0.8-1.7), although mean age at recurrence was comparable in men and women (50 years vs 49 years, P = .595). In women with a hormonal first event, median interval between first event and recurrence was 10.4 years versus 2.7 years in men (P < .001). This difference was not observed when only unprovoked events were considered (P = .938). The difference in lifetime risk of recurrent venous thrombosis between men and women in thrombophilic families can be explained by a younger age of women at time of first venous thrombosis due to hormonal risk factors, and a longer interval between a provoked first episode of venous thrombosis and recurrence in women.

Entities:  

Mesh:

Year:  2009        PMID: 19571315     DOI: 10.1182/blood-2009-04-215418

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

Review 2.  Predicting the risk of venous thromboembolism recurrence.

Authors:  John A Heit
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Authors:  Abrar Ahmad; Ashfaque A Memon; Jan Sundquist; Peter J Svensson; Bengt Zöller; Kristina Sundquist
Journal:  Gene       Date:  2018-01-09       Impact factor: 3.688

Review 5.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 6.  Estrogen and thrombosis: controversies and common sense.

Authors:  Thomas G DeLoughery
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

Review 7.  Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?

Authors:  Fionnuala Ní Áinle; Barry Kevane
Journal:  Blood Adv       Date:  2020-11-10

8.  Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.

Authors:  John A Heit; Brian D Lahr; Tanya M Petterson; Kent R Bailey; Aneel A Ashrani; L Joseph Melton
Journal:  Blood       Date:  2011-09-02       Impact factor: 22.113

9.  Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Authors:  Angela Mirela Soare; Constantin Popa
Journal:  J Med Life       Date:  2010 Oct-Dec

Review 10.  Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Authors:  James Douketis; Alberto Tosetto; Maura Marcucci; Trevor Baglin; Benilde Cosmi; Mary Cushman; Paul Kyrle; Daniela Poli; R Campbell Tait; Alfonso Iorio
Journal:  BMJ       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.